GSIE - ETF AI Analysis

Top Page

Goldman Sachs ActiveBeta International Equity ETF (GSIE)

Rating:66Neutral

Price Target:―

GSIE, the Goldman Sachs ActiveBeta International Equity ETF, has a solid overall rating driven by strong, diversified holdings in major global companies. High-quality positions like Novartis, HSBC, and AstraZeneca support the fund with robust financial performance, positive earnings outlooks, and generally reasonable valuations, while banks such as Santander and BBVA add strength but come with leverage, regional, and potential overbought risks. The main risk factor is the fund’s exposure to financials and some overvaluation or overbought signals in several holdings, which could lead to short-term volatility.

Positive Factors

Broad International Diversification

The fund spreads its investments across many countries such as Japan, the UK, Europe, Canada, and others, which helps reduce the impact of problems in any single market.

Healthy Sector Mix

Holdings are spread across financials, industrials, technology, health care, and several other sectors, limiting reliance on just one part of the economy.

Competitive Expense Ratio

The fund’s expense ratio is relatively low for an actively managed international strategy, helping investors keep more of their returns over time.

Negative Factors

Heavy Tilt Toward Financials

With a large share of assets in financial companies, the fund is more exposed to risks specific to banks and other financial institutions.

Mixed Performance Among Top Holdings

While some leading positions like ASML, Roche, and Advantest have shown strong gains, others such as Royal Bank of Canada, AstraZeneca, SAP, and Allianz have been weaker, which can dampen overall results.

Limited U.S. Exposure

The fund has only a modest allocation to U.S. stocks, so investors who want significant exposure to the U.S. market would need to pair it with another fund.

GSIE vs. SPDR S&P 500 ETF (SPY)

AUM5.44B

RegionDeveloped Markets

Expense Ratio0.25%

Beta0.67

IssuerGoldman Sachs

Inception DateNov 06, 2015

Dividend Yield2.55%

Asset ClassEquity

Index TrackedStuttgart Goldman Sachs ActiveBeta Intl.Equity (USD)

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume442,395

30 Day Avg. Volume528,563

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

49.67

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering637

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

GSIE Summary

GSIE is the Goldman Sachs ActiveBeta International Equity ETF, which follows the Stuttgart Goldman Sachs ActiveBeta International Equity index and invests in stocks from countries outside the U.S., such as Japan, the UK, and Germany. It owns many types of companies across sectors like finance, industrials, health care, and technology, including well-known names like ASML, Novartis, and HSBC. Investors might consider GSIE to diversify beyond the U.S. and spread their money across many international companies for long-term growth. A key risk is that international stock prices can be volatile and move up or down with global markets and currency changes.

How much will it cost me?The expense ratio for the Goldman Sachs ActiveBeta International Equity ETF (GSIE) is 0.25%, which means you’ll pay $2.50 per year for every $1,000 invested. This is lower than average for actively managed ETFs because it uses a factor-based strategy rather than traditional stock-picking, keeping costs relatively modest.

What would affect this ETF?The GSIE ETF, with its focus on developed markets outside the U.S., could benefit from economic growth in Europe and Asia, particularly if industries like financials and technology, which have significant weight in the fund, experience expansion. However, it may face challenges from rising interest rates or geopolitical tensions that could negatively impact international markets and sectors like financials and consumer cyclical. Additionally, regulatory changes in key regions or currency fluctuations could influence the ETF's performance.

GSIE Top 10 Holdings

GSIE’s story is all about international blue chips doing the heavy lifting, with a few notable soft spots. European health care names like Roche, Novartis, and AstraZeneca are rising and giving the fund a steady defensive backbone, while consumer giant Nestlé adds a slow‑and‑steady ballast. On the growth side, ASML and Japan’s Advantest are powering returns with strong momentum in the semiconductor space. Big global banks such as HSBC and Banco Santander are contributing, but SAP has been losing steam lately, slightly dragging on this otherwise broadly diversified, non‑U.S. portfolio.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	1.81%	$98.26M	€482.60B	82.23%	76 Outperform
ROG	Roche Holding AG	1.20%	$64.94M	CHF298.70B	43.81%	73 Outperform
NOVN	Novartis AG	1.18%	$64.02M	CHF246.66B	28.67%	80 Outperform
HSBA	HSBC Holdings	1.02%	$55.01M	£221.80B	43.57%	80 Outperform
AZN	AstraZeneca	0.94%	$50.82M	$320.89B	28.44%	80 Outperform
RY	Royal Bank Of Canada	0.93%	$50.61M	$239.22B	43.05%	75 Outperform
SAN	Banco Santander	0.83%	$45.01M	€156.31B	83.60%	73 Outperform
6857	Advantest	0.80%	$43.29M	¥18.57T	159.34%	75 Outperform
NESN	Nestlé SA	0.72%	$38.95M	CHF209.77B	7.73%	71 Outperform
ALV	Allianz	0.65%	$34.94M	€143.34B	15.57%	67 Neutral

GSIE Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

44.29

Positive

100DMA

42.74

Positive

200DMA

41.03

Positive

Market Momentum

MACD

0.62

Positive

RSI

64.95

Neutral

STOCH

76.35

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 45.66, equal to the 50-day MA of 44.29, and equal to the 200-day MA of 41.03, indicating a bullish trend. The MACD of 0.62 indicates Positive momentum. The RSI at 64.95 is Neutral, neither overbought nor oversold. The STOCH value of 76.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GSIE.

GSIE Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
GSIE	―	―	$5.44B	0.25%	66 Neutral
LVHI	―	―	$4.52B	0.40%	70 Outperform
IMTM	―	―	$3.80B	0.30%	68 Neutral
INTF	―	―	$3.30B	0.16%	65 Neutral
IDMO	―	―	$3.22B	0.25%	68 Neutral
PXF	―	―	$2.66B	0.43%	60 Neutral

Performance Comparison

GSIE

Goldman Sachs ActiveBeta International Equity ETF

46.72

11.76

33.64%

LVHI

Legg Mason International Low Volatility High Dividend ETF

―

IMTM

iShares MSCI Intl Momentum Factor ETF

―

INTF

iShares MSCI Intl Multifactor ETF

―

IDMO

Invesco S&P International Developed Momentum ETF

―

PXF

Invesco FTSE RAFI Developed Markets ex-U.S. ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents